<!DOCTYPE html>
<html lang="en">
<head>
  <!-- charset meta tag -->
  <meta charset="UTF-8" />
  <!-- / charset meta tag -->
  <!-- http-equiv meta tag -->
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <!-- / http-equiv meta tag -->
  <!-- keywords meta tag -->
  <meta name="keywords" content="ALBRIOZA" />
  <!-- / keywords meta tags -->
  <!-- description meta tag -->
  <meta name="description" content="ALBRIOZA" />
  <!-- / description meta tag -->
  <!-- viewport meta tag -->
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <!-- / viewport meta tag -->
  <title>Home</title>
  <!-- bootstrap css -->
  <link rel="stylesheet" href="./content/css/bootstrap.min.css" />
  <!-- custom stylesheet -->
  <link rel="stylesheet" href="./content/css/styles.min.css" />
  <!-- / custom stylesheet -->
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css">
  <link rel="stylesheet" media="all" href="https://use.typekit.net/yrx1oyi.css" />
</head>
<body>
  <header>
    <div class="top-menu-links text-right">
      <span>
        <a href="javascript:void(0)" class="pl-0">Important Safety Information</a>
        <a href="javascript:void(0)">Product Monograph</a>
        <a href="javascript:void(0)" class="act-support redirect-icon d-none d-lg-inline">ACT Support Program</a>
        <a href="javascript:void(0)" class="pr-0 pl-2 border-right-0"><span
            class="d-inline-block d-lg-none">FR</span><span class="d-none d-lg-inline">Français</span></a>
      </span>
    </div>
    <nav class="navbar navbar-expand-lg navbar-light ">
      <a class="navbar-brand pl-lg-0" href="javascript:void(0)"><img
          src="./content/images/style-images/albrioza-logo.png" /></a>
      <button class="navbar-toggler border-0" type="button" data-toggle="collapse" data-target="#navbarNavDropdown"
        aria-controls="navbarNavDropdown" aria-expanded="false" aria-label="Toggle navigation">
        <span class="mt-1"></span>
        <span class="mt-2"></span>
        <span class="mt-2"></span>
      </button>
      <div class="collapse navbar-collapse  d-block w-100 text-center" id="navbarNavDropdown">
        <button class="btn btn-secondary rounded-circle close-btn d-lg-none" data-toggle="collapse"
          data-target="#navbarNavDropdown">&times;</button>
        <a class="navbar-brand m-0 d-lg-none" href="javascript:void(0)"><img
            src="./content/images/style-images/albrioza-white-logo.png" /></a>
        <ul class="navbar-nav ml-auto">
          <!-- dropdown link -->
          <li class="nav-item dropdown">
            <a class="nav-link dropdown-toggle" href="javascript:void(0)" role="button" data-toggle="dropdown"
              aria-expanded="false">
              EFFICACY
            </a>
            <!-- dropdown menu -->
            <div class="dropdown-menu border-0 pb-lg-0">
              <a class="dropdown-item" href="javascript:void(0)">CENTAUR TRIAL</a>
              <a class="dropdown-item" href="javascript:void(0)">FUNCTION</a>
              <a class="dropdown-item" href="javascript:void(0)">ABOUT ALSFRS-R</a>
            </div>
          </li>
          <li class="nav-item">
            <a class="nav-link" href="javascript:void(0)">SAFETY PROFILE</a>
          </li>
          <li class="nav-item">
            <a class="nav-link" href="javascript:void(0)">MECHANISM OF ACTION</a>
          </li>
          <li class="nav-item">
            <a class="nav-link" href="javascript:void(0)">DOSING & ADMIN</a>
          </li>
          <li class="nav-item">
            <a class="nav-link" href="javascript:void(0)">MANAGING EXPECTATIONS</a>
          </li>
          <li class="nav-item">
            <a class="nav-link" href="javascript:void(0)">SUPPORT & RESOURCES</a>
          </li>
        </ul>
        <p class="text-white mb-0 d-lg-none">Get patients started today</p>
        <a class="nav-link btn btn-secondary position-relative d-lg-none" href="javascript:void(0)">Download enrolment
          Form</a>
        <a href="javascript:void(0)" class="redirect-icon-secondary text-white redirect-link d-lg-none position-relative fs-12">ACT Support Program</a>
      </div>
    </nav>
  </header>
  <main>
  </main>
  <section class="banner">
    <div class="container text-white">
      <h3 class="text-yellow text-uppercase">Introducing</h3>
      <h1 class="text-white">ALBRIOZATM: Demonstrated to slow the loss of function in ALS1†</h1>
      <p>ALBRIOZA ± SOC significantly slowed disease progression vs. placebo ± SOC over 24 weeks (as measured by rate
        of
        decline in ALSFRS-R; P=0.03).1†</p>
      <div class="row">
        <div class="col-md-6">
          <div class="card position-relative card-secondary">
            <p class="mb-0">MEAN ALSFRS-R SCORE WAS</p>
            <p class="text-green d-flex align-items-center pl-3 mb-ne-3"><span
                class="fs-40 font-weight-bolder">2.32</span><span
                class="text-uppercase fs-14 points-higher line-height-17">points higher
                with ALBRIOZA</span></p>
            <p class="text-green text-uppercase fs-14 line-height-17 pl-29 mb-ne-10">± SOC vs. placebo ± SOC</p>
            <p class="fs-12 line-height-18 text-center">after 24 weeks of treatment (P=0.03).1†‡</p>
            <button class="btn btn-secondary position-absolute">Discover the data</button>
          </div>
        </div>
        <div class="col-md-6">
          <div class="card mt-43 position-relative card-two card-secondary">
            <p class="mb-0">A FLEXIBLE ORAL SUSPENSION
            </p>
            <p> that can be administered
              by mouth or feeding tube1</p>
            <button class="btn btn-secondary position-absolute">LEARN ABOUT DOSING</button>
          </div>
        </div>
      </div>
      <p class="d-none d-lg-block">ALBRIOZA (sodium phenylbutyrate and ursodoxicoltaurine) is indicated for the
        treatment of patients with
        amyotrophic lateral sclerosis (ALS).
        ALBRIOZA has been issued marketing authorization with conditions, pending the results of trials to verify its
        clinical benefit. Patients should be advised of the nature of the authorization. For further information for
        ALBRIOZA, please refer to Health Canada’s Notice of Compliance with conditions - drug products web site:
        https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions.html
      </p>
    </div>

  </section>
  <section class="als-treatment-plan">
    <div class="card container bg-white">
      <h2 class="text-uppercase">A new therapy for your foundational ALS treatment plan</h2>
      <div class="row">
        <div class="col-sm-4">
          <div class="media d-block">
            <img src="content/images/content-images/functional-benefits.png" class="img-fluid"
              alt="Proven to provide functional benefits">
            <div class="media-body">
              <h5 class="my-3">PROVEN TO PROVIDE <br>FUNCTIONAL BENEFITS</h5>
              <p>In the CENTAUR trial, ALBRIOZA ± SOC significantly slowed disease progression vs. placebo ± SOC over
                24
                weeks (as measured by rate of decline in ALSFRS-R; P=0.03).1†‡</p>
              <a href="javascript:void(0)" class="btn btn-primary">EXPLORE EFFICACY</a>
            </div>
          </div>
        </div>
        <div class="col-sm-4">
          <div class="media d-block">
            <img src="content/images/content-images/safety-profile.png" class="img-fluid"
              alt="Demonstrated safety profile">
            <div class="media-body">
              <h5 class="my-3">DEMONSTRATED <br>SAFETY PROFILE</h5>
              <p>ALBRIOZA was generally well-tolerated in the pivotal clinical trial. The most common AEs were mainly
                gastrointestinal-related and occurred most often during the first
                3 weeks of therapy.1§</p>
              <a href="javascript:void(0)" class="btn btn-primary">SEE SAFETY PROFILE</a>
            </div>
          </div>
        </div>
        <div class="col-sm-4">
          <div class="media d-block">
            <img src="content/images/content-images/personalized-support.png" class="img-fluid"
              alt="Personalized support">
            <div class="media-body">
              <h5 class="my-3">PERSONALIZED <br>SUPPORT</h5>
              <p>The Amylyx Care Team (ACT)TM provides resources and services to support the care of people with ALS
                as they start and continue on ALBRIOZA.</p>
              <a href="javascript:void(0)" class="btn btn-primary">LEARN MORE ABOUT ACT</a>
            </div>
          </div>
        </div>
      </div>
      <p>
        † The efficacy of ALBRIOZA was assessed in a 24-week, multicenter, randomized, double-blind,
        placebo-controlled, parallel-group study of patients with familial or sporadic ALS. 137 patients were
        randomized 2:1 to receive ALBRIOZA or placebo. The primary efficacy endpoint was a comparison of the rate
        (slope) of reduction in total scores between ALBRIOZA plus SOC vs. SOC alone from baseline to Week 24 in the
        mITT population.1
      </p>
      <p>‡ The average baseline ALSFRS-R total score was 35.7 (5.78) in the ALBRIOZA treatment group and 36.7 (5.08)
        in the placebo group.1
        § The most common AEs (≥10%) observed in the ALBRIOZA group were diarrhea (18%) and abdominal pain (10%).1
        AE: adverse event; ALS: amyotrophic lateral sclerosis; ALSFRS-R: ALS Functional Rating Scale-Revised; SOC:
        standard of care therapies.</p>
      <h3>Establishing clear treatment expectations with your patients can be important</h3>
      <button class="btn btn-secondary">LEARN MORE</button>
    </div>
  </section>
  </main>
  <footer>
  </footer>
  <!-- jquery cdn -->
  <script src="./content/scripts/jquery.min.js"></script>
  <!-- / jquery cdn -->
  <script src="./content/scripts/script.min.js"></script>
  <script src="./content/scripts/bootstrap.min.js"></script>
</body>

</html>